194 related articles for article (PubMed ID: 16100476)
1. Evaluating benign and malignant musculoskeletal lesions with radionuclide angiography and SPECT using Tc-99m MIBI.
Ishiyama K; Tomura N; Okada K; Nagasawa H; Sashi R; Sasaki K; Sato K; Watarai J
Clin Nucl Med; 2005 Sep; 30(9):598-603. PubMed ID: 16100476
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MIBI scintigraphy in musculoskeletal tumors.
Pinkas L; Robinson D; Halperin N; Mindlin L; Cohenpour M; Baumer M; Home T
J Nucl Med; 2001 Jan; 42(1):33-7. PubMed ID: 11197977
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Tc-99m MIBI and Tl-201 uptake in musculoskeletal lesions.
Adalet I; Ozger H; Cantez S
Clin Nucl Med; 1996 Feb; 21(2):118-21. PubMed ID: 8697680
[TBL] [Abstract][Full Text] [Related]
4. The role of technetium-99m hexakis-2-methoxyisobutyl isonitrile in the detection of neoplastic lung lesions.
Santini M; Fiorello A; Mansi L; Rambaldi PF; Vicidomini G; Busiello L; Messina G; Nargi P
Eur J Cardiothorac Surg; 2009 Feb; 35(2):325-31. PubMed ID: 18996706
[TBL] [Abstract][Full Text] [Related]
5. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
[TBL] [Abstract][Full Text] [Related]
6. Value of 99m Tc-MIBI SPECT/CT in the localization of recurrent lesions in patients with suspected recurrent parathyroid carcinoma.
Guo YH; Huang JW; Wang Y; Lu R; Yang MF
Nucl Med Commun; 2023 Jan; 44(1):18-26. PubMed ID: 36437540
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-tetrofosmin scintigraphy in musculoskeletal tumours: the relationship between P-glycoprotein expression and tetrofosmin uptake in malignant lesions.
Yapar Z; Kibar M; Ozbarlas S; Yapar AF; Uguz A; Zorludemir S; Herdem M
Nucl Med Commun; 2002 Oct; 23(10):991-1000. PubMed ID: 12352598
[TBL] [Abstract][Full Text] [Related]
8. A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.
Demirel K; Kapucu O; Yücel C; Ozdemir H; Ayvaz G; Taneri F
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):642-50. PubMed ID: 12612810
[TBL] [Abstract][Full Text] [Related]
9. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography.
Kao CH; Shiau YC; Shen YY; Yen RF
Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of uptake and release of technetium-99m MIBI SPECT of pulmonary and mediastinal lesions.
Komori T; Narabayashi I; Matsui R; Tatsu Y; Sueyoshi K; Adachi I; Shimizu T; Namba R; Nakata Y
Ann Nucl Med; 1997 Aug; 11(3):227-32. PubMed ID: 9310172
[TBL] [Abstract][Full Text] [Related]
12. Comparison of technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography to detect recurrent or residual nasopharyngeal carcinomas after radiotherapy.
Shiau YC; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2001; 21(3C):2213-7. PubMed ID: 11501849
[TBL] [Abstract][Full Text] [Related]
13. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
Caner B; Kitapçl M; Unlü M; Erbengi G; Calikoğlu T; Göğüş T; Bekdik C
J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
[TBL] [Abstract][Full Text] [Related]
15. [Technetium 99-m sestamibi bone scan in musculo-skeletal neoplasms].
Robinson D; Pinkas L; Mindlin L; Halperin N; Horn T
Harefuah; 1997 Dec; 133(11):509-14, 592. PubMed ID: 9451886
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
[TBL] [Abstract][Full Text] [Related]
17. Investigation of blood perfusion and metabolic activity of brain tumours in adults by using 99mTc-methoxyisobutylisonitrile.
Petrovic NS; Grujicic D; Artiko VM; Sobic-Saranovic DP; Gajic MM; Jaksic E; Grajic MM; Antonovic OJ; Petrovic MN; Obradovic VB
Nucl Med Commun; 2010 Nov; 31(11):962-73. PubMed ID: 20802363
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism.
Araz M; Çayir D; Erdoğan M; Uçan B; Çakal E
Nucl Med Commun; 2017 Feb; 38(2):117-123. PubMed ID: 27846041
[TBL] [Abstract][Full Text] [Related]
20. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
